Substance Replacement Therapy in the Context of the COVID-19 Pandemic in Québec: Clinical Guidance for Prescribers

This is a guidance document based on BCCSU's Risk Mitigation int the Context of Dual Health Emergencies updated to include forms, resources, and regulations that are specific to Quebec (see BCCSU's document for more information). It also includes some information on COVID specific changes to prescribing guidelines for OAT, benzos, and psychostimulants. This document suggests that the opioid supply in Quebec does not contain as much fentanyl as is found in other regions of Canada and therefore hydromorphone as safe supply may be more effective in Quebec than elsewhere. This document does not include specific dosing outside of previously established guidelines for common prescription drugs. It also does not appear to contain any voices of people who would use safe supply services. A number of appendicies and forms are attached that are all specific to Quebec and all are in French.